Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome
- 15 November 2007
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 110 (10) , 3729-3734
Abstract
The 8p11 myeloproliferative syndrome (EMS) is an aggressive, atypical stem cell myeloproliferative disorder associated with chromosome translocations that disrupt and constitutively activate FGFR1 by fusion to diverse partner genes. To explore the possibility of targeted therapy for EMS, we have investigated the use of TKI258, a multitargeted receptor tyrosine kinase inhibitor with activity against FGFR, VEGFR, PDGFR, FLT3, and KIT that is currently being assessed for the treatment of a variety of malignancies in phase 1 clinical studies. The viability of Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 was specifically inhibited by TKI258 with IC50 values of 150 nM and 90 nM, respectively. Inhibition was accompanied by dose-dependent inhibition of phosphorylation of each fusion gene, ERK, and STAT5. TKI258 also specifically inhibited proliferation and survival of the FGFR1OP2-FGFR1–positive KG1 and KG1A cell lines, resulting in increased levels of apoptosis. Primary cells from EMS patients showed significant, dose-dependent responses in liquid culture and in methylcellulose colony assays compared with controls. This work provides evidence that targeted therapy may be beneficial for patients with EMS.Keywords
This publication has 27 references indexed in Scilit:
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophiliaLeukemia, 2006
- The development of imatinib as a therapeutic agent for chronic myeloid leukemiaBlood, 2005
- Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further casesThe Hematology Journal, 2004
- FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in miceBlood, 2004
- Caspase-like activity in programmed nuclear death during conjugation of Tetrahymena thermophilaCell Death & Differentiation, 2003
- Assignment1 of ZNF262 to human chromosome band 1p34→p32 by in situ hybridizationCytogenetic and Genome Research, 1999
- Unconventional rapid ERK1,2 activation is indispensable for proliferation of the growth factor-independent myeloid leukemic cell line KG1Leukemia, 1998
- HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin ExpressionScience, 1982
- Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating ActivityScience, 1978